The Life Sciences Law Review covers a total of 37 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies.
In this seventh edition, we can see that corporate governance is becoming a more vital and all-encompassing topic with each year that passes.
The Securities Litigation Review is a guided introduction to the international varieties of enforcing rights related to the issuance and exchange of publicly traded securities.
The Review provides an introduction to healthcare economies and their legal frameworks in 16 jurisdictions. While hugely diverse, it is possible to discern common challenges and similar approaches in very different countries.